• It 'makes sense' to look into test-tube burger   Monday, 5 Aug 2013 | 11:55 AM ET
    It 'makes sense' to look into test-tube burger

    John Authers, senior investment columnist at the Financial Times, says it makes sense to look into meat alternatives, but affordability will be key.

  • Test-tube burger, anyone?   Monday, 5 Aug 2013 | 11:45 AM ET
    Test-tube burger anyone?

    The $325,000 in-vitro burger could help lead to sustainable meat production, according to the Netherlands-based researcher Mark Post.

  • Ancient master goldsmiths were master crooks, too Friday, 26 Jul 2013 | 2:44 PM ET
    Metal workers from the time of ancient Rome were experts at shiny finishes.

    Metal workers 2,000 years ago perfected plating techniques that modern methods can't touch. Some probably coated cheap metal or wood objects in a gilded skin and sold them for big profits. NBC reports.

  • Delaying retirement and dementia?   Tuesday, 16 Jul 2013 | 4:47 PM ET
    Delaying retirement and dementia?

    A French government research agency shows that putting off retirement can delay dementia. Dr. Nancy Snyderman, NBC's chief medical editor, explains the "use it or lose it" strategy.

  • Engineers juggle objects using levitation Tuesday, 16 Jul 2013 | 12:27 PM ET
    A photochemical liquid switch can be made by combining acoustically levitated drops.

    "Harry Potter" magic? No, it's acoustic levitation. Researchers have created a device that uses sound waves to make small solid objects and liquid droplets float in the air.

  • Fish Oil's Cancer Risk   Thursday, 11 Jul 2013 | 4:50 PM ET
    Fish Oil's Cancer Risk

    Fred Hutchinson Cancer Research Center released a study revealing men with concentrations of omega-3 fatty acids have an increased risk of prostate cancer. Co-author Alan Kristal shares more from their study on the best selling supplement.

  • Genetic Modification: Seed Companies Fight Back Tuesday, 25 Jun 2013 | 4:10 PM ET

    Genetically modified seeds are used in corn and soybeans grown in the US, but the debate over the effects of tinkering with Mother Nature hasn't gone away.

  • An Anti-Competitive Decision?   Monday, 17 Jun 2013 | 7:44 PM ET
    An Anti-Competitive Decision?

    A panel of experts and Larry Kudlow discuss the Supreme Court's refusal to declare "pay to delay" deals between pharmaceutical companies and generic drugmakers illegal.

  • Labels on bags of snack foods indicate they are non-GMO food products.

    Last year $2 billion worth of products were sold with a label saying they do not contain ingredients from genetically modified organisms, but the claim wasn't backed by regulators.

  • The Science of Golf: It's More Than Smacking a Little White Ball

    Steve Green, Chevron vp of public affairs, talks about a new educational video series produced for grades K through 12, which examines the role of technology and engineering in the game of golf.

  • SCOTUS: Human Genes Can't Be Patented   Thursday, 13 Jun 2013 | 7:10 PM ET
    SCOTUS: Human Genes Can't Be Patented

    The Supreme Court unanimously ruled that human genes cannot be patented, with CNBC's Bertha Coombs; David Resnick, Nixon Peabody LLP; Mitch Epner, Wilk Auslander Counsel; and Rich Lowry, National Review.

  • SCOTUS Rules on Patenting DNA   Thursday, 13 Jun 2013 | 1:25 PM ET
    SCOTUS Rules on Patenting DNA

    In a unanimous decision, the Supreme Court justices say naturally occurring human genes cannot be patented, with CNBC's Hampton Pearson.

  • Obamacare's Med School Dilemma   Wednesday, 12 Jun 2013 | 7:52 PM ET
    Obamacare's Med School Dilemma

    Discussing the big problems Obamacare creates for hospitals, doctors, and even medical students, with Dr. Beth Haynes M.D. of Benjamin Rush Society, Brian Blank, UNC-Chapel Hill Medical Student.

  • Monsanto Saying No to GMO Crop Expansion in Europe Friday, 31 May 2013 | 2:56 PM ET
    Farmer Matt Wiggeim unstraps a delivery of Monsanto DeKalb brand seed corn on a farm in Princeton, Ill.

    Monsanto is not pushing for expansion of genetically modified crops in most of Europe as opposition to its biotech seeds in many countries remains high, company officials said.

  • Asteroid to Pass By Earth   Friday, 31 May 2013 | 2:45 PM ET
    Asteroid to Pass By Earth

    CNBC's Jane Wells reports the name of the asteroid flying by Earth is "1998 QE2," and it won't get any closer to Earth than 3.6 million miles.

  • Leading the Fight Against Cancer   Friday, 31 May 2013 | 2:30 PM ET
    Leading the Fight Against Cancer

    Bristol-Myers is presenting data on its next-generation drug Nivolumab, which treats tumors, reports CNBC's Bertha Coombs.

  • Asteroid to Miss Earth By 3.6 Million Miles

    Asteroid alert! CNBC's Jane Wells reports on the asteroid passing by Earth today.

  • Searching For a Cancer Breakthrough   Friday, 31 May 2013 | 1:02 PM ET
    Searching For a Cancer Breakthrough

    Gilead is taking aim at cancer, and the company is presenting early-stage data at the oncology conference on treatment for blood cancer, reports CNBC's Bertha Coombs.

  • QE2 astroid has a moon.

    There's a big asteroid that's due to sail past Earth on Friday, and it comes with a moon twice as big as the ocean liner that shares the meteor's name.

  • Game Changers: Personalized Medicine   Friday, 31 May 2013 | 12:00 AM ET
    Game Changers: Personalized Medicine

    The cost of sequencing DNA has plunged from $100 million in 2001 to less than $10,000 today. Amit Bhalla, Citi, offers insight on the developing technologies for personalized care.